References
- Le Quesne P.M., McLeod J.G. Peripheral neuropathy following a single exposure to arsenic. J. Neurol. Sci. 1977; 32: 437
- Heyman A., Pfeiffer J. B., Jr., Willett R.W., Taylor H.M. Peripheral neuropathy caused by arsenic intoxication. N. Engl. J. Med. 1956; 254: 401
- Jenkins R.B. Inorganic arsenic and the nervous system. Brain 1966; 89: 479
- Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics5th ed. Macmillan, New York 1975; 924
- Arena J.M. Poisoning-Toxicology, Symptoms, Treatments3rd ed. Thomas, Springfield, Illinois 1974; 120–121
- Lerman B.B., Nabile A., Green D. Megaloblastic, dyserythropoietic anemia following arsenic ingestion. Ann. Clin. Lab. Sci. 1980; 10: 515
- Buchet J.P., Lauwreys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 1980; 48: 71
- Ochs S. Fast transport of materials in mammalian nerve fibers. Science 1972; 176: 252
- Information from Manufacturer. Monsanto Agricultural Products Company, St. Louis, Missouri 1981
- Pomroy C., Charbonneau S.M., McCullough R.S., Tam G.K.H. Human retention studies with 74As. Toxicol. Appl. Pharmacol. 1980; 53: 550